Efficacy [qlco]
Safety [hcpp]
Single [popg]
Pill [phsu]
Combination [qlco]
Amlodipine 10 MG [clnd]
Plus [qlco]
valsartan 160 MG [clnd]
hypertensive [fndg]
Patients [podg]
Controlled [ftcn]
Amlodipine [orch, phsu]
mg/mg [qnco]
Plus [qlco]
olmesartan [orch, phsu]
free [ftcn]
Combination [qlco]
Objective [inpr]
Patients [podg]
Hypertension, moderate [fndg]
grade 2 [inpr]
Defined [cnce]
Systolic blood pressure [clna]
mmHg [qnco]
Diastolic blood pressure [clna]
mmHg [qnco]
Current [tmco]
Guidelines [inpr]
recommend [idcn]
Initial [tmco]
Combination Therapy [topp]
Rapid [qlco]
Dose Adjustment [hlca]
Blood Pressure [orgf]
Goal [inpr]
Study [mnob]
investigated [ftcn]
Efficacy [qlco]
TOLERABILITY [resa]
Single [popg]
Pill [phsu]
Combination [qlco]
Amlodipine [orch, phsu]
mg/mg [qnco]
Plus [qlco]
valsartan [orch, phsu]
Patients [podg]
Controlled [ftcn]
free [ftcn]
Combination [qlco]
Amlodipine [orch, phsu]
mg/mg [qnco]
Plus [qlco]
olmesartan [orch, phsu]
Methods [inpr]
prospective [resa]
OPEN LABEL [resa]
randomized [resa]
Trial [resa]
Patients [podg]
Sitting diastolic blood pressure [fndg]
mmHg [qnco]
Trough [qnco]
Entered [qlco]
treatment [ftcn]
Phase [tmco]
Amlodipine [orch, phsu]
mg/mg [qnco]
Plus [qlco]
olmesartan [orch, phsu]
free [ftcn]
Combination [qlco]
Daily [tmco]
Patients [podg]
Diastolic blood pressure [clna]
Uncontrolled [qlco]
Switch [mnob]
Secondary to [tmco]
treatment [ftcn]
Phase [tmco]
Amlodipine [orch, phsu]
mg/mg [qnco]
Plus [qlco]
valsartan [orch, phsu]
Primary [qlco]
Efficacy [qlco]
Variable [qlco]
reduction [npop]
Diastolic blood pressure [clna]
Compared [acty]
intent [qlco]
baseline [bodm]
Systolic blood pressure [clna]
Diastolic blood pressure [clna]
mmHg [qnco]
Decreased [qnco]
14 7 [qnco]
mmHg [qnco]
Patients [podg]
N NOS [aapp, imft]
Subsequent [tmco]
treatment [ftcn]
Amlodipine [orch, phsu]
mg/mg [qnco]
Plus [qlco]
valsartan [orch, phsu]
4 Weeks [tmco]
Reduced [qlco]
Systolic blood pressure [clna]
mmHg [qnco]
P NOS [aapp, imft]
Diastolic blood pressure [clna]
mmHg [qnco]
mmHg [qnco]
P NOS [aapp, imft]
Combination [qlco]
Amlodipine [orch, phsu]
mg/mg [qnco]
Plus [qlco]
valsartan [orch, phsu]
Well [qlco]
Observed [ftcn]
adverse events [fndg]
Patients [podg]
Phase 2 [tmco]
Consistent [idcn]
Known [qlco]
Drug [phsu]
Profile [lbpr]
Conclusions [idcn]
Study [mnob]
Design [acty]
reflect [menp]
Typical [qlco]
practice [menp]
Patients [podg]
Controlled [ftcn]
free [ftcn]
Combination [qlco]
a o [dsyn]
Single [popg]
Pill [phsu]
Combination [qlco]
Amlodipine [orch, phsu]
mg/mg [qnco]
Plus [qlco]
valsartan [orch, phsu]
Statistically [ocdi]
Additional [ftcn]
reduction [npop]
Well [qlco]
limitations [ftcn]
Design [acty]
OPEN LABEL [resa]
Controlled [ftcn]
Design [acty]
Short-term [tmco]
treatment [ftcn]
Taken [cnce]
account [idcn]
